Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pyruvate dehydrogenase E1-alpha deficiency is the most frequent form of pyruvate dehydrogenase deficiency (PDHD) characterized by variable lactic acidosis, impaired psychomotor development, hypotonia and neurological dysfunction.
Features include always present findings: Respiratory failure, Metabolic acidosis, Intellectual disability, and Lactic acidosis and others; and very common findings: Low muscle tone (hypotonia). 36 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Dystonia, Seizure, Enlarged brain ventricles (ventriculomegaly) |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Brain shrinkage (cerebral atrophy) |
Lab test results | 3 | Increased circulating pyruvate concentration, Increased circulating lactate concentration, Decreased activity of the pyruvate dehydrogenase complex |
Head and neck | 2 | Microcephaly, Abnormal facial shape |
Eyes | 2 | Abnormal eye movements (abnormality of eye movement), Ptosis |
Lungs and breathing | 1 | Respiratory failure |
Metabolism | 1 | Metabolic acidosis |
PDHA1 function has not been fully characterized.
Pyruvate dehydrogenase E1-alpha deficiency is associated with mutations in the PDHA1 gene on chromosome X.
Genetic testing for PDHA1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features, 1 very common feature, 2 common features.
Estimated prevalence: Unknown (Unknown prevalence).
5 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, other interventions, and gene therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03056794](https://clinicaltrials.gov/study/NCT03056794) | Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies | — | University of Pittsburgh | RECRUITING |
[NCT02616484](https://clinicaltrials.gov/study/NCT02616484) | Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: | PHASE3 | Saol Therapeutics Inc | ACTIVE_NOT_RECRUITING |
[NCT06887777](https://clinicaltrials.gov/study/NCT06887777) | Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) | PHASE2 | Assistance Publique - Hôpitaux de Paris | RECRUITING |
[NCT06340685](https://clinicaltrials.gov/study/NCT06340685) | Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency | PHASE1 | Jirair Krikor Bedoyan | RECRUITING |
[NCT01793168](https://clinicaltrials.gov/study/NCT01793168) | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford | — | Sanford Health | RECRUITING |
4 publications have been identified in PubMed for pyruvate dehydrogenase E1-alpha deficiency. Research spans Other (25%), Review / Meta-Analysis (25%), and Case Report / Case Series (25%).
Ma H (2026). [PMID: 41780638](https://pubmed.ncbi.nlm.nih.gov/41780638/). *Mol Metab*. [Basic Science / Preclinical]
Guo Y (2025). [PMID: 40121184](https://pubmed.ncbi.nlm.nih.gov/40121184/). *FEMS Yeast Res*. [Review / Meta-Analysis]
Nguyen TTN (2024). [PMID: 39720099](https://pubmed.ncbi.nlm.nih.gov/39720099/). *Frontiers in pediatrics*. [Case Report / Case Series]
Laxmi V (2024). [PMID: 37787965](https://pubmed.ncbi.nlm.nih.gov/37787965/). *Indian J Pediatr*. [Other]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:01 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center